Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2016 | Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents-A drug repurposing strategy. | Wu, CH; Bai, LY; Tsai, MH; Chu, PC; Chiu, CF; Chen, MY; Chiu, SJ; Chiang, JH; Weng, JR | Scientific reports 6, 27540 | | | |
2015 | PHRF1 promotes genome integrity by modulating non-homologous end-joining. | Chang, CF; Chu, PC; Wu, PY; Yu, MY; Lee, JY; Tsai, MD; Chang, MS | Cell death & disease 6, e1716 | | | |
2016 | Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells. | Chu, PC; Yang, MC; Kulp, SK; Salunke, SB; Himmel, LE; Fang, CS; Jadhav, AM; Shan, YS; Lee, CT; Lai, MD; Shirley, LA; Bekaii-Saab, T; Chen, CS | Oncogene 35, 3897-3908 | | | |
2006 | Silencing of p29 affects DNA damage responses with UV irradiation. | Chu, PC; Yang, YC; Lu, YT; Chen, HT; Yu, LC; Chang, MS | Cancer research 66(17), 8484-91 | | | |
2013 | Suppression of prostate epithelial proliferation and intraprostatic progrowth signaling in transgenic mice by a new energy restriction-mimetic agent. | Berman-Booty, LD; Chu, PC; Thomas-Ahner, JM; Bolon, B; Wang, D; Yang, T; Clinton, SK; Kulp, SK; Chen, CS | Cancer prevention research 6(3), 232-241 | | | |
2012 | Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent. | Wei, S; Chu, PC; Chuang, HC; Hung, WC; Kulp, SK; Chen, CS | PloS one 7(10), e47298 | | | |
2012 | The mRNA-stabilizing factor HuR protein is targeted by beta-TrCP protein for degradation in response to glycolysis inhibition. | Chu, PC; Chuang, HC; Kulp, SK; Chen, CS | The Journal of biological chemistry 287(52), 43639-43650 | | | |